Deep search
Rewards
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
Past 24 hours
Any time
Past hour
Past 7 days
Past 30 days
Best match
Most recent
precisionmedicineonline
19h
Astellas' Vyloy Approved in Europe as First-Line Treatment for CLDN18.2-Positive Gastric Cancer
The European Commission approval was based on two Phase III trials showing Vyloy plus chemo improved survival outcomes versus chemo alone.
precisionmedicineonline
17h
AstraZeneca, Daiichi Sankyo Hoping to Sway FDA of Dato-DXd Benefit Despite Overall Survival Miss
Despite showing a progression-free survival benefit, the antibody-drug conjugate did not improve overall survival in HR-positive, HER2-negative or -low breast cancer.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
Left note, bail denied
Devils Tower climber dies
Texas sues Biden admin
Seeks NIL compensation
Calif. school phone ban law
John becomes Category 3
Colo. shooter found guilty
Asks to be put on NY ballot
1/3 think they have CTE
Returning Indian antiquities
Didn't authorize apology
UAE president WH meeting
NY reports death from EEE
Friedkin set to buy Everton
1951 kidnap victim found
Ammonia-powered tug sails
Reds fire manager
Closing last full-size store
California sues ExxonMobil
Co-founder testifies
Tech ban proposed
Bulls escape MA rodeo
NE electoral change blocked
Astronauts return to Earth
More troops to Middle East
No govt. shutdown for now
FBI: Violent crime declined
SpaceX plans Mars missions
Feedback